1. Home
  2. SGHT vs QUIK Comparison

SGHT vs QUIK Comparison

Compare SGHT & QUIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$4.33

Market Cap

235.0M

Sector

Health Care

ML Signal

HOLD

Logo QuickLogic Corporation

QUIK

QuickLogic Corporation

HOLD

Current Price

$18.13

Market Cap

211.8M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGHT
QUIK
Founded
2011
1988
Country
United States
United States
Employees
N/A
51
Industry
Medical Specialities
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
235.0M
211.8M
IPO Year
2021
1997

Fundamental Metrics

Financial Performance
Metric
SGHT
QUIK
Price
$4.33
$18.13
Analyst Decision
Buy
Buy
Analyst Count
7
1
Target Price
$9.08
$11.00
AVG Volume (30 Days)
298.9K
424.6K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
28.16
N/A
EPS
N/A
N/A
Revenue
$77,363,000.00
$20,112,000.00
Revenue This Year
$11.67
$75.17
Revenue Next Year
$10.39
$16.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.81
$4.80
52 Week High
$9.24
$18.88

Technical Indicators

Market Signals
Indicator
SGHT
QUIK
Relative Strength Index (RSI) 55.08 78.21
Support Level $3.29 $5.61
Resistance Level $5.25 N/A
Average True Range (ATR) 0.30 1.38
MACD 0.04 0.52
Stochastic Oscillator 38.41 91.29

Price Performance

Historical Comparison
SGHT
QUIK

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

About QUIK QuickLogic Corporation

QuickLogic Corp is a fabless semiconductor company developing programmable logic semiconductor technologies, including embedded Field Programmable Gate Array (eFPGA) intellectual property (IP) and specialized FPGA devices. Its product offerings include the eFPGA IP licensing business and associated professional services, as well as a range of FPGA silicon products, including EOS, ArcticLink III, PolarPro 3, PolarPro II, PolarPro, and Eclipse II products, among others. The company's customers come from various markets, including aerospace and defense, industrial and infrastructure systems, data processing and computing platforms, and certain embedded and edge computing applications. Geographically, it generates maximum revenue from North America and the rest from Asia Pacific and Europe.

Share on Social Networks: